Breaking News Instant updates and real-time market news.

AMRN

Amarin

$7.17 /

-0.115 (-1.58%)

11:25
05/22/20
05/22
11:25
05/22/20
11:25

Amarin call volume above normal and directionally bullish

Bullish option flow detected in Amarin with 14,504 calls trading, 1.6x expected, and implied vol increasing over 5 points to 85.64%. 5/22 weekly 7.5 calls and 5/29 weekly 8 calls are the most active options, with total volume in those strikes near 4,100 contracts. The Put/Call Ratio is 0.17. Earnings are expected on July 29th.

AMRN Amarin
$7.17 /

-0.115 (-1.58%)

05/22/20 Roth Capital
Roth Capital says buy Amarin as at-risk generic launch unlikely
05/22/20 Roth Capital
Roth sees low likelihood of at-risk generic launch of Vascepa
05/22/20 Roth Capital
Amarin selloff today a buying opportunity, says Roth Capital
05/22/20 Cantor Fitzgerald
Cantor Fitzgerald still positive on Amarin despite Hikma's generic approval

TODAY'S FREE FLY STORIES

Hot Stocks
RedHill Biopharma plans to initiate Phase 3 study of RHB-204 in Q3 » 07:07
05/27/20
05/27
07:07
05/27/20
07:07
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

Following recent data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Hot Stocks
Compugen doses first patient in COM701 Phase 1 monotherapy expansion cohort » 07:06
05/27/20
05/27
07:06
05/27/20
07:06
CGEN

Compugen

$14.28 /

-0.02 (-0.14%)

Compugen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGEN Compugen
$14.28 /

-0.02 (-0.14%)

CGEN Compugen
$14.28 /

-0.02 (-0.14%)

05/26/20 JMP Securities
Compugen resumed with an Outperform at JMP Securities
05/13/20
Fly Intel: Top five analyst initiations
05/13/20 Stifel
Compugen initiated with a Buy at Stifel
05/07/20
Fly Intel: Top five analyst initiations
CGEN Compugen
$14.28 /

-0.02 (-0.14%)

CGEN Compugen
$14.28 /

-0.02 (-0.14%)

Hot Stocks
Synthetic Biologics signs option to license SYN-020 for age-related diseases » 07:06
05/27/20
05/27
07:06
05/27/20
07:06
SYN

Synthetic Biologics

$0.34 /

+0.0113 (+3.49%)

Synthetic Biologics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYN Synthetic Biologics
$0.34 /

+0.0113 (+3.49%)

SYN Synthetic Biologics
$0.34 /

+0.0113 (+3.49%)

05/06/20 Alliance Global Partners
Synthetic Biologics price target lowered to $1.25 from $2.25 at Alliance Global
Hot Stocks
RedHill Biopharma aims to enroll up to 40 patients in Phase 2a study of opaganib » 07:06
05/27/20
05/27
07:06
05/27/20
07:06
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Initiation
Monarch Casino initiated with a Buy at SunTrust » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
MCRI

Monarch Casino

$38.17 /

+1.1 (+2.97%)

SunTrust analyst Barry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCRI Monarch Casino
$38.17 /

+1.1 (+2.97%)

MCRI Monarch Casino
$38.17 /

+1.1 (+2.97%)

06:13 Today SunTrust
Monarch Casino initiated with a Buy at SunTrust
04/27/20 Stifel
Monarch Casino upgraded to Buy from Hold at Stifel
04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
01/06/20 Jefferies
Monarch Casino upgraded to Buy from Hold at Jefferies
MCRI Monarch Casino
$38.17 /

+1.1 (+2.97%)

Initiation
PDS Biotechnology initiated with a Buy at Alliance Global Partners » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
PDSB

PDS Biotechnology

$1.17 /

-0.01 (-0.85%)

, MRK

Merck

$77.26 /

+0.89 (+1.17%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDSB PDS Biotechnology
$1.17 /

-0.01 (-0.85%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

PDSB PDS Biotechnology
$1.17 /

-0.01 (-0.85%)

03/30/20 H.C. Wainwright
PDS Biotechnology downgraded to Neutral from Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
03/09/20 Noble Capital
PDS Biotechnology initiated with an Outperform at Noble Capital
11/07/19 H.C. Wainwright
PDS Biotechnology Q3 results miss, but studies on track, says H.C. Wainwright
MRK Merck
$77.26 /

+0.89 (+1.17%)

05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/23/20 Mizuho
Merck business disruptions have been modest, says Mizuho
MRK Merck
$77.26 /

+0.89 (+1.17%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

Hot Stocks
First United Corp: Driver has issued another misleading message to shareholders » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
FUNC

First United Corp

$14.54 /

+0.79 (+5.75%)

First United Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FUNC First United Corp
$14.54 /

+0.79 (+5.75%)

Recommendations
Kala Pharmaceuticals price target raised to $17 from $14 at H.C. Wainwright » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
KALA

Kala Pharmaceuticals

$12.70 /

-0.37 (-2.83%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

05/13/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data
03/20/20 Wedbush
Kala Pharmaceuticals added to Best Ideas List at Wedbush
03/18/20 H.C. Wainwright
Kala Pharmaceuticals price target raised to $13 from $10 at H.C. Wainwright
03/09/20 Jefferies
Kala's Eysuvis could be preferred treatment for dry eye flare, says Jefferies
KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

General news
FX Update: The dollar dropped back » 07:05
05/27/20
05/27
07:05
05/27/20
07:05

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
RedHill Biopharma expects initiation of Phase 3 study of RHB-204 in Q3 » 07:04
05/27/20
05/27
07:04
05/27/20
07:04
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Hot Stocks
Papa John's provides update on ongoing COVID-19 response » 07:04
05/27/20
05/27
07:04
05/27/20
07:04
PZZA

Papa John's

$74.13 /

-3.58 (-4.61%)

Papa John's provided…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

05/14/20 Northcoast
Papa John's sustaining strong comp growth as states reopen, says Northcoast
05/07/20 Stephens
Papa John's price target raised to $83 from $61 at Stephens
05/07/20 Credit Suisse
Papa John's price target raised to $84 from $71 at Credit Suisse
05/01/20 Northcoast
Papa John's downgraded to Neutral from Buy at Northcoast
PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

Hot Stocks
Investor group issues presentation to correct GameStop's 'misleading' claims » 07:03
05/27/20
05/27
07:03
05/27/20
07:03
GME

GameStop

$4.42 /

+0.235 (+5.62%)

Hestia Capital Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$4.42 /

+0.235 (+5.62%)

GME GameStop
$4.42 /

+0.235 (+5.62%)

04/21/20 Baird
GameStop FY20 EPS target cut at Baird
03/27/20 Baird
GameStop trneds to remain weak despite recent increase, says Baird
03/20/20
Fly Intel: Top five analyst downgrades
03/20/20 Benchmark
GameStop does not qualify as an essential retailer, says Benchmark
GME GameStop
$4.42 /

+0.235 (+5.62%)

GME GameStop
$4.42 /

+0.235 (+5.62%)

GME GameStop
$4.42 /

+0.235 (+5.62%)

GME GameStop
$4.42 /

+0.235 (+5.62%)

Earnings
RedHill Biopharma reports Q1 EPS (5c), consenus (24c) » 07:03
05/27/20
05/27
07:03
05/27/20
07:03
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

Reports Q1 revenue $1.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Earnings
CollPlant reports Q1 non-GAAP EPS (21c), consensus (23c) » 07:02
05/27/20
05/27
07:02
05/27/20
07:02
CLGN

CollPlant

$10.15 /

+0.06 (+0.59%)

Reports Q1 revenue $609K…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGN CollPlant
$10.15 /

+0.06 (+0.59%)

CLGN CollPlant
$10.15 /

+0.06 (+0.59%)

04/03/20 H.C. Wainwright
CollPlant price target raised to $11 from $7 at H.C. Wainwright
General news
MBA Mortgage Applications Composite Index data reported » 07:02
05/27/20
05/27
07:02
05/27/20
07:02

Week of 5/22 MBA Mortgage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Bristol-Myers receives EC approval for Zeposia » 07:01
05/27/20
05/27
07:01
05/27/20
07:01
BMY

Bristol-Myers

$60.33 /

-0.45 (-0.74%)

Bristol Myers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$60.33 /

-0.45 (-0.74%)

BMY Bristol-Myers
$60.33 /

-0.45 (-0.74%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$60.33 /

-0.45 (-0.74%)

BMY Bristol-Myers
$60.33 /

-0.45 (-0.74%)

BMY Bristol-Myers
$60.33 /

-0.45 (-0.74%)

BMY Bristol-Myers
$60.33 /

-0.45 (-0.74%)

Hot Stocks
Latam Airlines files for voluntary protection under Chapter 11 reorg. process » 07:01
05/27/20
05/27
07:01
05/27/20
07:01
LTM

Latam Airlines

$1.68 /

-0.89 (-34.63%)

LATAM Airlines Group S.A.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LTM Latam Airlines
$1.68 /

-0.89 (-34.63%)

LTM Latam Airlines
$1.68 /

-0.89 (-34.63%)

05/26/20 Raymond James
Latam Airlines downgraded to Underperform from Outperform at Raymond James
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
04/24/20 Morgan Stanley
Latam Airlines downgraded to Underweight from Equal Weight at Morgan Stanley
04/16/20 HSBC
Latam Airlines upgraded to Buy from Hold at HSBC
LTM Latam Airlines
$1.68 /

-0.89 (-34.63%)

LTM Latam Airlines
$1.68 /

-0.89 (-34.63%)

LTM Latam Airlines
$1.68 /

-0.89 (-34.63%)

Initiation
Microsoft initiated with a Buy at Summit Insights » 06:57
05/27/20
05/27
06:57
05/27/20
06:57
MSFT

Microsoft

$181.64 /

-1.94 (-1.06%)

Summit Insights analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$181.64 /

-1.94 (-1.06%)

MSFT Microsoft
$181.64 /

-1.94 (-1.06%)

05/18/20 RBC Capital
Microsoft price target raised to $200 from $196 at RBC Capital
05/15/20 Morgan Stanley
Security another large market opportunity for Microsoft, says Morgan Stanley
05/06/20 Craig-Hallum
MicroVision rise driven by Microsoft speculation, says Craig-Hallum
04/30/20 Credit Suisse
Microsoft price target raised to $195 from $190 at Credit Suisse
MSFT Microsoft
$181.64 /

-1.94 (-1.06%)

MSFT Microsoft
$181.64 /

-1.94 (-1.06%)

MSFT Microsoft
$181.64 /

-1.94 (-1.06%)

MSFT Microsoft
$181.64 /

-1.94 (-1.06%)

MSFT Microsoft
$181.64 /

-1.94 (-1.06%)

Recommendations
Lipocine price target raised to $3 from $2 at H.C. Wainwright » 06:56
05/27/20
05/27
06:56
05/27/20
06:56
LPCN

Lipocine

$0.96 /

-0.0311 (-3.15%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPCN Lipocine
$0.96 /

-0.0311 (-3.15%)

LPCN Lipocine
$0.96 /

-0.0311 (-3.15%)

11/11/19 H.C. Wainwright
Lipocine price target lowered to $2 from $5 at H.C. Wainwright
11/11/19 Ladenburg
Lipocine downgraded to Neutral from Buy at Ladenburg
Recommendations
EPR Properties price target lowered to $40 from $45 at RBC Capital » 06:55
05/27/20
05/27
06:55
05/27/20
06:55
EPR

EPR Properties

$32.27 /

+2.11 (+7.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPR EPR Properties
$32.27 /

+2.11 (+7.00%)

EPR EPR Properties
$32.27 /

+2.11 (+7.00%)

04/22/20 JPMorgan
JPMorgan downgrades EPR after only15% of April rents get collected
04/22/20 JPMorgan
EPR Properties downgraded to Neutral from Overweight at JPMorgan
04/08/20 RBC Capital
EPR Properties has highest concentration of AMC leases, says RBC Capital
04/07/20 Citi
EPR Properties downgraded to Sell from Neutral at Citi
EPR EPR Properties
$32.27 /

+2.11 (+7.00%)

EPR EPR Properties
$32.27 /

+2.11 (+7.00%)

Syndicate
Regeneron 11.83M share Secondary priced at $515.00 » 06:55
05/27/20
05/27
06:55
05/27/20
06:55
REGN

Regeneron

$545.22 /

-24.72 (-4.34%)

BofA and Goldman Sachs…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$545.22 /

-24.72 (-4.34%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

06:45 Today Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 RBC Capital
BioMarin among Sanofi's most intriguing potential targets, says RBC Capital
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
REGN Regeneron
$545.22 /

-24.72 (-4.34%)

  • 27
    May
REGN Regeneron
$545.22 /

-24.72 (-4.34%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

General news
European stock markets have rallied » 06:55
05/27/20
05/27
06:55
05/27/20
06:55

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
AerCap shouldn't need capital markets funding until 2021, says Stephens » 06:53
05/27/20
05/27
06:53
05/27/20
06:53
AER

AerCap

$30.58 /

+1.74 (+6.03%)

After AerCap announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AER AerCap
$30.58 /

+1.74 (+6.03%)

AER AerCap
$30.58 /

+1.74 (+6.03%)

05/26/20 JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
05/06/20 Deutsche Bank
AerCap price target lowered to $44 from $63 at Deutsche Bank
05/06/20 Deutsche Bank
AerCap price target lowered to $44 from $63 at Deutsche Bank
05/06/20 Barclays
AerCap price target raised to $39 from $32 at Barclays
AER AerCap
$30.58 /

+1.74 (+6.03%)

AER AerCap
$30.58 /

+1.74 (+6.03%)

AER AerCap
$30.58 /

+1.74 (+6.03%)

Upgrade
Unite Group upgraded to Overweight from Neutral at JPMorgan » 06:53
05/27/20
05/27
06:53
05/27/20
06:53
UTGPF

Unite Group

$0.00 /

+ (+0.00%)

JPMorgan analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UTGPF Unite Group
$0.00 /

+ (+0.00%)

05/06/20 Peel Hunt
Unite Group downgraded to Hold from Buy at Peel Hunt
04/02/20 Jefferies
Unite Group upgraded to Buy from Hold at Jefferies
Periodicals
Quibi's advertisers look for new deals amid low viewership, WSJ reports » 06:52
05/27/20
05/27
06:52
05/27/20
06:52
PEP

PepsiCo

$129.70 /

-0.82 (-0.63%)

, YUM

Yum! Brands

$87.92 /

+0.69 (+0.79%)

, BUD

AB InBev

$44.37 /

+3.49 (+8.54%)

, WMT

Walmart

$123.85 /

-0.47 (-0.38%)

Quibi's performance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$129.70 /

-0.82 (-0.63%)

YUM Yum! Brands
$87.92 /

+0.69 (+0.79%)

BUD AB InBev
$44.37 /

+3.49 (+8.54%)

WMT Walmart
$123.85 /

-0.47 (-0.38%)

PEP PepsiCo
$129.70 /

-0.82 (-0.63%)

05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
04/29/20 Guggenheim
PepsiCo price target raised to $145 from $134 at Guggenheim
04/29/20 Cowen
PepsiCo price target raised to $156 from $135 at Cowen
YUM Yum! Brands
$87.92 /

+0.69 (+0.79%)

05/26/20 JPMorgan
Yum! Brands price target raised to $91 from $81 at JPMorgan
05/15/20
Fly Intel: Top five analyst upgrades
05/14/20 Stifel
Restaurant Brands, Yum Brands upgraded to Buy at Stifel
05/14/20 Stifel
Yum! Brands upgraded to Buy from Hold at Stifel
BUD AB InBev
$44.37 /

+3.49 (+8.54%)

05/20/20 JPMorgan
AB InBev upgraded to Neutral from Underweight at JPMorgan
05/13/20 Morgan Stanley
AB InBev price target lowered to EUR 39 from EUR 40 at Morgan Stanley
04/20/20 Morgan Stanley
AB InBev downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/20 Evercore ISI
Beer production not resuming in Mexico, says Evercore ISI
WMT Walmart
$123.85 /

-0.47 (-0.38%)

05/21/20 Bernstein
Walmart built for crisis, investing despite uncertainty, says Bernstein
05/20/20 Credit Suisse
Walmart price target raised to $135 from $127 at Credit Suisse
05/20/20 Guggenheim
Walmart price target raised to $140 from $135 at Guggenheim
05/20/20 Deutsche Bank
Walmart price target raised to $139 from $134 at Deutsche Bank
PEP PepsiCo
$129.70 /

-0.82 (-0.63%)

YUM Yum! Brands
$87.92 /

+0.69 (+0.79%)

BUD AB InBev
$44.37 /

+3.49 (+8.54%)

WMT Walmart
$123.85 /

-0.47 (-0.38%)

PEP PepsiCo
$129.70 /

-0.82 (-0.63%)

YUM Yum! Brands
$87.92 /

+0.69 (+0.79%)

BUD AB InBev
$44.37 /

+3.49 (+8.54%)

WMT Walmart
$123.85 /

-0.47 (-0.38%)

PEP PepsiCo
$129.70 /

-0.82 (-0.63%)

YUM Yum! Brands
$87.92 /

+0.69 (+0.79%)

BUD AB InBev
$44.37 /

+3.49 (+8.54%)

WMT Walmart
$123.85 /

-0.47 (-0.38%)

PEP PepsiCo
$129.70 /

-0.82 (-0.63%)

YUM Yum! Brands
$87.92 /

+0.69 (+0.79%)

BUD AB InBev
$44.37 /

+3.49 (+8.54%)

WMT Walmart
$123.85 /

-0.47 (-0.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.